T0	Limitation 20703 20709	First,
T1	Limitation 21195 21197	To
T2	Limitation 21402 21409	Second,
T3	Limitation 21517 21523	Third,
T4	Limitation 21661 21668	Fourth,
T5	Limitation 18645 18647	We
T6	Limitation 18524 18530	Second
T7	Limitation 18917 18922	Third
T8	Limitation 19406 19408	We
T9	Limitation 19084 19087	The
T10	ExperimentalPhaseDuration 18924 18971	we assessed endpoints only twice 6 months apart
T11	SampleSize 20752 20827	we were unable to enroll our original calculated sample due to slow accrual
T12	SampleSize 21289 21400	an even larger sample size than originally calculated may have been required to detect a significant difference
T13	ExperimentalPhaseDuration 21410 21432	6 month trial duration
T14	VerySpecificPopulation 21560 21659	the majority of our participants were unemployed females with significant neurocognitive impairment
T15	VerySpecificPopulation 21669 21724	all our participants were black Xhosa speaking Africans
T16	Generalization 21731 21773	limits the generalizability of our results
T17	Patient 18532 18614	participants may have become more familiar with the neuropsychological assessments
T18	Patient 18763 18809	cannot completely exclude some practice effect
T19	ExperimentalPhaseDuration 19084 19186	The trajectory of natural disease, placebo, and lithium would be best described in longer term studies
T20	RelevantOutcomeExcluded 19526 19599	we missed social comorbidity improvement explained by trial participation
